- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:37 | US FDA accepts sBLA for GSK's Jemperli for broader endometrial cancer use | ||
| Mi | OSR Holdings, SillaJen sign MoU to pursue drug development | ||
| Di | BMS to boost CAR T cell therapy production with Cellares deal | ||
| Mo | Merck's PREVYMIS gets Health Canada's approval for CMV disease prevention | ||
| Fr | SK pharmteco signs agreement to manufacture Ferring's ADSTILADRIN | ||
| 18.04. | Biocon signs licensing and supply deal for diabetes drug in Brazil | ||
| 17.04. | Orladeyo gains approval in Brazil for HAE prevention | ||
| 16.04. | Telix Pharmaceuticals secures FDA fast track status for TLX101-CDx | ||
| 15.04. | Immuno-oncology company Portage Biotech to evaluate strategic alternatives | ||
| 12.04. | NICE recommends Novartis' CAR-T therapy for leukaemia | ||
| 11.04. | TORL BioTherapeutics secures $158m for oncology pipeline development | ||
| 10.04. | Invenra, Astellas sign bispecific antibody discovery agreement | ||
| 09.04. | FDA approves ViiV Healthcare's Dovato for adolescent HIV treatment | ||
| 08.04. | US FDA grants breakthrough status to Dizal's sunvozertinib | ||
| 05.04. | Teva signs licensing deal with mAbxience for oncology biosimilar candidate | ||
| 04.04. | Alterome Therapeutics secures $132m in Series B funding | ||
| 03.04. | Bavarian Nordic announces commercial availability of mpox vaccine in US | ||
| 02.04. | Solid Biosciences' SGT-003 receives rare pediatric disease designation | ||
| 01.04. | US FDA grants orphan drug designation to Biostar Pharma's utidelone | ||
| 29.03. | FDA approves Gilead's Vemlidy sNDA for paediatric HBV patients | ||
| 28.03. | Santhera's vamorolone NDA receives priority review in China | ||
| 27.03. | Cipla enters deal to distribute Sanofi's CNS products in India | ||
| 26.03. | Q32 Bio concludes merger deal with Homology Medicines | ||
| 25.03. | EMA CHMP recommends marketing authorisation for Novartis' PNH treatment | ||
| 22.03. | FDA approves Italfarmaco's Duvyzat for DMD treatment |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
